Abstract:Objective: To examine the clinical effect of minimally invasive duodenum preserving pancreatic head resection(DPPHR) for benign and pre-malignant lesions of pancreatic head. Methods: The clinical data of patients with diagnosis of benign or pre-malignant pancreatic head tumor were retrospectively collected and analyzed,all of them underwent laparoscopic or robotic DPPHR between October 2015 and September 2021 at Division of Gastrointestinal and Pancreatic surgery,Zhejiang Provincial People's Hospital. Thirty-three patients were enrolled with 10 males and 23 females. The age(M(IQR)) was 54(32) years old(range: 11 to 77 years old) and the body mass index was 21.9(2.9)kg/m2(range: 18.1 to 30.1 kg/m2). The presenting symptoms included abdominal pain(n=12), Whipple triad(n=2), and asymptomatic(n=19). There were 7 patients with hypertension and 1 patient with diabetes mellitus. There were 19 patients who were diagnosed as American Society of Anesthesiologists class Ⅰ and 14 patients who were diagnosed as class Ⅱ. The student t test,U test, χ2 test or Fisher exact test was used to compare continuous data or categorized data,respectively. All the perioperative data and metabolic morbidity were analyzed and experiences on minimally invasive DPPHR were concluded. Results: Fourteen patients underwent laparoscopic DPPHR,while the rest of 19 patients received robotic DPPHR. Indocyanine green fluorescence imaging was used in 19 patients to guide operation. Five patients were performed pancreatico-gastrostomy and the rest 28 patients underwent pancreaticojejunostomy. Pathological outcomes confirmed 9 solid pseudo-papillary neoplasms, 9 intraductal papillary mucinous neoplasms, 7 serous cystic neoplasms, 6 pancreatic neuroendocrine tumors, 1 mucous cystic neoplasm, 1 chronic pancreatitis. The operative time was (309.4±50.3) minutes(range:180 to 420 minutes),and the blood loss was (97.9±48.3)ml(range:20 to 200 ml). Eighteen patients suffered from postoperative complications,including 3 patients experienced severe complications(Clavien-Dindo Grade ≥Ⅲ). Pancreatic fistula occurred in 16 patients,including 8 patients with biochemical leak,7 patients with grade B pancreatic fistula and 1 patient with grade C pancreatic fistula. No one suffered from the duodenal necrosis and none perioperative death was occurred. The length of hospital stay was 14(7) days (range:6 to 87 days). The follow-up was 22.6(24.5)months(range:2 to 74 months). None suffered from recurrence or metastasis. During the follow-up,all the patients were free of refractory cholangitis. Moreover,in the term of endocrine dysfunction,no postoperative new onset of diabetes mellitus were observed in the long-term follow-up. However,in the view of exocrine insufficiency,pancreatic exocrine insufficiency and non-alcoholic fatty liver disease (NAFLD) was complicated in 2 and 1 patient,respectively,with the supplement of pancreatic enzyme,steatorrhea and weight loss relieved,but NAFLD was awaited to be seen. Conclusions: Minimally invasive DPPHR is feasible and safe for benign or pre-malignant lesions of pancreatic head. Moreover,it is oncological equivalent to pancreaticoduodenectomy with preservation of metabolic function without refractory cholangitis.

Minimally Invasive Pancreas Surgery: Is There a Benefit?

Minimally invasive pancreaticoduodenectomy for periampullary disease: a comprehensive review of literature and meta-analysis of outcomes compared with open surgery

Minimally Invasive Pancreatoduodenectomy is Associated with Lower Morbidity Compared to Open Pancreatoduodenectomy an Updated Meta-Analysis of Randomized Controlled Trials and High-Quality Nonrandomized Studies

Pancreatic cancer: Open or minimally invasive surgery?

Assessing the Postoperative Behaviors of Minimally-Invasive Pancreatoduodenectomy Versus Open Pancreatoduodenectomy

The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection

[Clinical Analysis of Minimal Invasive Surgical Treatment for Pancreatic Neuroendocrine Tumors].

Minimally invasive total pancreatectomy with islet autotransplantation for chronic pancreatitis: the robotic approach

Clinical Effect of Minimally Invasive Duodenum Preserving Pancreatic Head Resection for Benign and Pre-Malignant Lesions of Pancreatic Head

Minimally Invasive Preservation Versus Splenectomy During Distal Pancreatectomy: a Systematic Review and Meta-Analysis

The Necessity to Found "Minimal Invasive Surgery in Pancreas and Stomach" from Laparoscopic Pancreatic Surgery

Minimal Invasive Surgery in the Treatment of Neuroendocrine Tumors of the Pancreas

Safety and effectiveness of minimally invasive central pancreatectomy versus open central pancreatectomy: a systematic review and meta-analysis

Do Patients Benefit More from Robot Assisted Approach Than Conventional Laparoscopic Distal Pancreatectomy? A Meta-Analysis of Perioperative and Economic Outcomes.

Minimally invasive distal pancreatectomy for pancreatic adenocarcinoma: A propensity-matched national analysis on surgical outcomes and healthcare disparities

A Current Status Between Laparoscopic and Robotic Resection of Pancreatic Malignant: A Systematic Review

Minimal invasive surgery in treatment of pancreas cystic neoplasm：a report of 236 cases

A Comparative Analysis of Open Versus Minimally Invasive Pancreatoduodenectomies

Advances in pancreas surgery: robotic pancreaticoduodenectomy

Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study

A Comparative Study Between Minimally Invasive and Traditional Open Surgery in Treating Patients with Pancreatic Body or Tail Lesions